Long term Use of Clopidogrel for Patients with Stents or Acute Coronary Syndrome: A Review of Clinical and Cost-effectiveness and Guidelines
CADTH
Record ID 32014000103
English
Authors' recommendations:
There appears to be uncertainty regarding the effectiveness of use of clopidogrel beyond one year. Results from the included studies were inconsistent and the majority of the studies were retrospective. In the evidence based guidelines there were no strong recommendations for use of clopidogrel beyond one year.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/aug-2013/RC0469-Clopidogrel%20LT-Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Acute Coronary Syndrome
- Platelet Aggregation Inhibitors
- Ticlopidine
- Stents
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.